4 Results for "

CHS828

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CHS828" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-10079
CAS No.: 200484-11-3
Purity:  99.28%
Synonyms: GMX1778
Target:  

NAMPT Apoptosis

Research Areas:  

Cancer

CHS-828 (GMX1778) is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), with an IC50 less than 25 nM. CHS-828 (GMX1778) exerts a cytotoxic effect by decreasing the cellular level of NAD + and exhibits a potent anticancer activity .
loading...
    loading...
Cat. No.: HY-10079R
CAS No.: 200484-11-3
Synonyms: GMX1778 (Standard)
Research Areas:  

Cancer

CHS-828 (Standard) is the analytical standard of CHS-828. This product is intended for research and analytical applications. CHS-828 (GMX1778) is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), with an IC50 less than 25 nM. CHS-828 (GMX1778) exerts a cytotoxic effect by decreasing the cellular level of NAD+ and exhibits a potent anticancer activity .
loading...
    loading...
Cat. No.: HY-10079A
CAS No.: 1160589-73-0
Synonyms: GMX1778 (nicotinate)
Target:  

NAMPT Apoptosis

Research Areas:  

Cancer

CHS-828 nicotinate is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), with an IC50 less than 25 nM. CHS-828 nicotinate (GMX1778) exerts a cytotoxic effect by decreasing the cellular level of NAD + and exhibits a potent anticancer activity .
loading...
    loading...
Cat. No.: HY-125147
CAS No.: 1375557-33-7
Target:  

NAMPT

Research Areas:  

Cancer

A-1293201 is a substrate-independent NAMPT inhibitor with antitumor activity. A-1293201 effectively reduces the total cellular NAD +/NADH (NADt) level, subsequently leading to ATP depletion and cancer cell death. In addition, A-1293201 can effectively overcome the acquired resistance mechanism of the NAMPT Y18 mutant to CHS-828 (HY-10079) .
loading...
    loading...